Second Sight Medical (EYES) Picks Up Chatter Ahead of CNBC Coverage
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech stocks weigh on Wall Street as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- U.S. EV market shows signs of bottoming out: Bernstein
Second Sight Medical Products, Inc. (Nasdaq: EYES) to Ring The Nasdaq Stock Market Closing Bell in Celebration of IPO
November 19, 2014 8:23 AM ESTADVISORY, Nov. 19, 2014 (GLOBE NEWSWIRE) --
What:Â
Second Sight Medical Products, Inc. (Nasdaq: EYES) will visit the Nasdaq MarketSite in Times Square. Second Sight develops, manufactures and markets the Argus II implantable visual prosthetic device that restores functional vision to individuals blinded by outer retinal degenerations. Second Sight management will be joined by users of the Argus II device, board members, and employees to celebrate the companys IPO.
In honor of the occasion, Robert Greenberg, President and CEO will ring the Closing Bell.Â
Where:
Nasdaq MarketSite 4... More
